Business
Covid: Oxford/AstraZeneca vaccine delivery to EU to be cut by 60% – The Guardian
Official says supply will be halved in first quarter of 2021 due to production problems
AstraZeneca is to cut deliveries of its Covid-19 vaccine to the EU by 60% in the first quarter of the year due to production problems, a senior official has told Reuters.
The jab it developed with the University of Oxford is already in widespread use in the UK, but the European Union has not yet approved it. It is expected to make a decision by 29 January.
AstraZeneca said in a statement to Agence-France Presse that if EU approval is granted, the initial volumes will be lower than anticipated.
The…
-
Noosa News15 hours agoIncrease in extreme weather events poses ‘substantial risk’ to blood supplies, researchers warn
-
General19 hours agoGerman palliative care doctor with alleged ‘lust for murder’ accused of killing 15 patients
-
Noosa News23 hours agoTributes flow for Geham wife and mother after husband charged with murder
-
Noosa News15 hours agoHow to find out your TikTok personality – and become a ‘citizen scientist’